Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Total Current Liabilities (2016 - 2025)

Wave Life Sciences' Total Current Liabilities history spans 11 years, with the latest figure at $95.1 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities fell 14.32% year-over-year to $95.1 million; the TTM value through Dec 2025 reached $95.1 million, down 14.32%, while the annual FY2025 figure was $95.1 million, 14.32% down from the prior year.
  • Total Current Liabilities reached $95.1 million in Q4 2025 per WVE's latest filing, up from $85.9 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $186.4 million in Q4 2023 to a low of $31.6 million in Q3 2021.
  • Average Total Current Liabilities over 5 years is $99.3 million, with a median of $87.4 million recorded in 2025.
  • Peak YoY movement for Total Current Liabilities: plummeted 71.15% in 2021, then surged 160.68% in 2023.
  • A 5-year view of Total Current Liabilities shows it stood at $64.2 million in 2021, then grew by 11.4% to $71.5 million in 2022, then skyrocketed by 160.68% to $186.4 million in 2023, then tumbled by 40.49% to $111.0 million in 2024, then decreased by 14.32% to $95.1 million in 2025.
  • Per Business Quant, the three most recent readings for WVE's Total Current Liabilities are $95.1 million (Q4 2025), $85.9 million (Q3 2025), and $87.4 million (Q2 2025).